Search Results - "Garey, Kevin"

Refine Results
  1. 1
  2. 2
  3. 3
  4. 4

    Heterogeneity and lyophilization comparison of stool processing for gastrointestinal bile acid measurement by LC-MS/MS by Hu, Chenlin, Wang, Weiqun, Garey, Kevin W

    “…[Display omitted] •Fecal bile acid (BA) analysis is an emerging area of gut microbiome research.•Sample preparation procedures for fecal BA analysis are not…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7
  8. 8

    Emerging Options for the Prevention and Management of Clostridioides difficile Infection by Gonzales-Luna, Anne J., Carlson, Travis J., Garey, Kevin W.

    Published in Drugs (New York, N.Y.) (01-02-2023)
    “…Agents in development for the prevention or treatment of Clostridioides difficile infection can be split into three broad categories: antibiotics, microbiome…”
    Get full text
    Journal Article
  9. 9

    Microscopy methods for Clostridioides difficile by Hu, Chenlin, Garey, Kevin W.

    Published in Anaerobe (01-04-2024)
    “…Microscopic technologies including light and fluorescent, transmission electron microscopy (TEM), scanning electron microscopy (SEM), and cryo-electron…”
    Get full text
    Journal Article
  10. 10

    Development and validation of LC-MS/MS for quantifying omadacycline from stool for gut microbiome studies by Hu, Chenlin, Wang, Weiqun, Jo, Jinhee, Garey, Kevin W.

    “…•Antimicrobial pharmacokinetics is an emerging area of gut microbiome research.•Omadacyline is a tetracycline-class antibiotic with potent activity against…”
    Get full text
    Journal Article
  11. 11

    Economic health care costs of blood culture contamination: A systematic review by Dempsey, Casey, Skoglund, Erik, Muldrew, Kenneth L., Garey, Kevin W.

    Published in American journal of infection control (01-08-2019)
    “…Blood culture contamination with gram-positive organisms is a common occurrence in patients suspected of bloodstream infections, especially in emergency…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14

    Bifidobacterium dentium Fortifies the Intestinal Mucus Layer via Autophagy and Calcium Signaling Pathways by Engevik, Melinda A, Luk, Berkley, Chang-Graham, Alexandra L, Hall, Anne, Herrmann, Beatrice, Ruan, Wenly, Endres, Bradley T, Shi, Zhongcheng, Garey, Kevin W, Hyser, Joseph M, Versalovic, James

    Published in mBio (18-06-2019)
    “…Much remains unknown about how the intestinal microbiome interfaces with the protective intestinal mucus layer. species colonize the intestinal mucus layer and…”
    Get full text
    Journal Article
  15. 15

    Estimating Clostridioides difficile infection-associated readmission rates: A systematic review and meta-analysis by Eubank, Taryn A, Jantarathaneewat, Kittiya, Jo, Jinhee, Garey, Kevin W

    “…The economic burden of infection (CDI) is considerable and mostly associated with a high frequency of hospitalizations. Numerous publications have demonstrated…”
    Get full text
    Journal Article
  16. 16

    Nonmammalian models to study Clostridioides difficile infection; a systematic review by Hu, Chenlin, Garey, Kevin W.

    Published in Anaerobe (01-02-2023)
    “…Clostridioide difficile is the leading cause of diarrhea disease worldwide and is a CDC-designated urgent threat level pathogen. Mammalian models are commonly…”
    Get full text
    Journal Article
  17. 17

    A Comprehensive Update on the Problem of Blood Culture Contamination and a Discussion of Methods for Addressing the Problem by Doern, Gary V, Carroll, Karen C, Diekema, Daniel J, Garey, Kevin W, Rupp, Mark E, Weinstein, Melvin P, Sexton, Daniel J

    Published in Clinical microbiology reviews (01-01-2020)
    “…In this review, we present a comprehensive discussion of matters related to the problem of blood culture contamination. Issues addressed include the scope and…”
    Get full text
    Journal Article
  18. 18

    Estimated Clinical and Economic Impact through Use of a Novel Blood Collection Device To Reduce Blood Culture Contamination in the Emergency Department: a Cost-Benefit Analysis by Skoglund, Erik, Dempsey, Casey J, Chen, Hua, Garey, Kevin W

    Published in Journal of clinical microbiology (01-01-2019)
    “…Blood culture contamination results in increased hospital costs and exposure to antimicrobials. We evaluated the potential clinical and economic benefits of an…”
    Get full text
    Journal Article
  19. 19

    Review Article: Safety of Live Biotherapeutic Products Used for the Prevention of Clostridioides difficile Infection Recurrence by Gonzales-Luna, Anne J, Carlson, Travis J, Garey, Kevin W

    Published in Clinical infectious diseases (05-12-2023)
    “…Abstract Live biotherapeutic products (LBPs) represent a new class of therapeutics indicated to prevent the recurrence of Clostridioides difficile infection…”
    Get full text
    Journal Article
  20. 20

    Impact of Clostridioides difficile infection on patient-reported quality of life by Han, Zheyi, Lapin, Brittany, Garey, Kevin W., Donskey, Curtis J., Deshpande, Abhishek

    “…Objective:We investigated the quality of life (QoL) of patients hospitalized with C. difficile infection (CDI).Design:Prospective survey study.Setting:US…”
    Get full text
    Journal Article